Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome.

[1]  N. Mishra,et al.  Placental DNA methylation changes in detection of tetralogy of Fallot , 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  C. Rosenfeld.  The placenta‐brain‐axis , 2020, Journal of neuroscience research.

[3]  K. Mozhui,et al.  Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter , 2020, Clinical Epigenetics.

[4]  B. Lester,et al.  Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome. , 2020, The Journal of pediatrics.

[5]  Dong-mei Wang,et al.  Adrenomedullin: an important participant in neurological diseases , 2020, Neural regeneration research.

[6]  S. Vishweswaraiah,et al.  Artificial Intelligence and the detection of pediatric concussion using epigenomic analysis , 2020, Brain Research.

[7]  N. Mishra,et al.  Artificial intelligence analysis of newborn leucocyte epigenomic markers for the prediction of autism , 2019, Brain Research.

[8]  Wei Zhou,et al.  Integrative analysis of DNA methylation and gene expression identified cervical cancer-specific diagnostic biomarkers , 2019, Signal Transduction and Targeted Therapy.

[9]  Ali Torkamani,et al.  Artificial intelligence in clinical and genomic diagnostics , 2019, Genome Medicine.

[10]  K. Harron,et al.  Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada , 2019, PLoS medicine.

[11]  D. Preen,et al.  Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review , 2019, CNS Drugs.

[12]  Dana E. Feldman,et al.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders , 2019, Front. Psychiatry.

[13]  V. Troiani,et al.  The imperative of clinical and molecular research on neonatal opioid withdrawal syndrome , 2019, Molecular Psychiatry.

[14]  S. Saxena,et al.  Addressing the opioid crisis globally , 2019, World psychiatry : official journal of the World Psychiatric Association.

[15]  B. Zuckerman,et al.  Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population , 2019, JAMA network open.

[16]  N. Mishra,et al.  Deep Learning/Artificial Intelligence and Blood-Based DNA Epigenomic Prediction of Cerebral Palsy , 2019, International journal of molecular sciences.

[17]  L. Farrer,et al.  The genetics and epigenetics of Neonatal Abstinence Syndrome. , 2019, Seminars in fetal & neonatal medicine.

[18]  Justyna A. Karolak,et al.  Epigenetically dysregulated genes and pathways implicated in the pathogenesis of non-syndromic high myopia , 2019, Scientific Reports.

[19]  H. Jones,et al.  Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions. , 2019, Journal of addiction medicine.

[20]  R. Pique-Regi,et al.  Differentially expressed gene networks, biomarkers, long noncoding RNAs, and shared responses with cocaine identified in the midbrains of human opioid abusers , 2019, Scientific Reports.

[21]  Angela M. Miller,et al.  Evaluation of State-Mandated Reporting of Neonatal Abstinence Syndrome — Six States, 2013–2017 , 2019, MMWR. Morbidity and mortality weekly report.

[22]  Kwanjeera Wanichthanarak,et al.  Rise of Deep Learning for Genomic, Proteomic, and Metabolomic Data Integration in Precision Medicine , 2018, Omics : a journal of integrative biology.

[23]  Marie J. Hayes,et al.  Epigenetic variation in OPRM1 gene in opioid‐exposed mother‐infant dyads , 2018, Genes, brain, and behavior.

[24]  Angela M. Miller,et al.  Educational Disabilities Among Children Born With Neonatal Abstinence Syndrome , 2018, Pediatrics.

[25]  T. Wright,et al.  Screening Pregnant Women and Their Neonates for Illicit Drug Use: Consideration of the Integrated Technical, Medical, Ethical, Legal, and Social Issues , 2018, Front. Pharmacol..

[26]  Amy Heerema-McKenney,et al.  Defense and infection of the human placenta , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[27]  N. Mishra,et al.  Placental epigenetics for evaluation of fetal congenital heart defects: Ventricular Septal Defect (VSD) , 2018, bioRxiv.

[28]  Yupu Liang,et al.  Oxycodone Self-Administration Induces Alterations in Expression of Integrin, Semaphorin and Ephrin Genes in the Mouse Striatum , 2018, Front. Psychiatry.

[29]  Yixue Li,et al.  Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers , 2018, Genome Medicine.

[30]  Matthew M Davis,et al.  Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004–2014 , 2018, Pediatrics.

[31]  Amy L. Salisbury,et al.  Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes. , 2018, Drug and alcohol dependence.

[32]  C. Figueiredo,et al.  Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and Prospects , 2018, Stem cells international.

[33]  Alexander M. Morin,et al.  Choice of surrogate tissue influences neonatal EWAS findings , 2017, BMC Medicine.

[34]  Fadhl M Alakwaa,et al.  Deep Learning Accurately Predicts Estrogen Receptor Status in Breast Cancer Metabolomics Data , 2017, bioRxiv.

[35]  L. Webster.  Risk Factors for Opioid-Use Disorder and Overdose. , 2017, Anesthesia and analgesia.

[36]  T. Hickish,et al.  Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone‐Maintained Opioid‐Dependent Mothers , 2017, The Journal of pediatrics.

[37]  R. Dupont.  The opioid epidemic is an historic opportunity to improve both prevention and treatment , 2017, Brain Research Bulletin.

[38]  D. Werb,et al.  The North American opioid epidemic: current challenges and a call for treatment as prevention , 2017, Harm Reduction Journal.

[39]  Inna Chervoneva,et al.  Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome , 2017, The New England journal of medicine.

[40]  Yoon Suk Kim,et al.  Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification , 2017, Experimental &Molecular Medicine.

[41]  H. Mactier,et al.  Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers , 2017, American Journal of Perinatology.

[42]  Dehua Chui,et al.  Prophylactic Melatonin Attenuates Isoflurane‐Induced Cognitive Impairment in Aged Rats through Hippocampal Melatonin Receptor 2 – cAMP Response Element Binding Signalling , 2017, Basic & clinical pharmacology & toxicology.

[43]  Davida M. Schiff,et al.  A Public Health Response to Opioid Use in Pregnancy , 2017, Pediatrics.

[44]  R. Urman,et al.  Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2). , 2017, Pain physician.

[45]  Timothy J. Peters,et al.  Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling , 2016, Genome Biology.

[46]  Xia Zhang,et al.  Pain control by melatonin: Physiological and pharmacological effects , 2016, Experimental and therapeutic medicine.

[47]  J. Kaprio,et al.  Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders. , 2016, International review of neurobiology.

[48]  P. Sobolewski,et al.  Genome-Wide DNA Methylation Analysis and Epigenetic Variations Associated with Congenital Aortic Valve Stenosis (AVS) , 2016, PloS one.

[49]  E. Ziętkiewicz,et al.  Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies , 2015, BMC Genomics.

[50]  H. Jones,et al.  Neonatal abstinence syndrome: Historical perspective, current focus, future directions. , 2015, Preventive medicine.

[51]  J. Davis,et al.  Opioids in pregnancy and neonatal abstinence syndrome. , 2015, Seminars in perinatology.

[52]  Marie J. Hayes,et al.  Variations in opioid receptor genes in neonatal abstinence syndrome. , 2015, Drug and alcohol dependence.

[53]  A. Singh,et al.  Genetic alterations of DNA methylation machinery in human diseases. , 2015, Epigenomics.

[54]  S. Eschrich,et al.  Expanding Epigenomics to Archived FFPE Tissues: An Evaluation of DNA Repair Methodologies , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[55]  J. Olcese,et al.  Genetic deletion of MT1/MT2 melatonin receptors enhances murine cognitive and motor performance , 2014, Neuroscience.

[56]  Marie J. Hayes,et al.  Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome. , 2014, The Journal of pediatrics.

[57]  D. Khanna,et al.  Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies , 2014, Annals of the rheumatic diseases.

[58]  M. Zheng,et al.  The Netrin-1 receptor DCC is a regulator of maladaptive responses to chronic morphine administration , 2014, BMC Genomics.

[59]  C. J. Mistry,et al.  Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence , 2014, Current psychiatry reviews.

[60]  Luzhu Chen,et al.  Two novel mutations of the NCSTN gene in Chinese familial acne inverse , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[61]  B. Christensen,et al.  Review of processing and analysis methods for DNA methylation array data , 2013, British Journal of Cancer.

[62]  K. Bucholz,et al.  DSM-5 criteria for substance use disorders: recommendations and rationale. , 2013, The American journal of psychiatry.

[63]  C. Albrecht,et al.  RNA degradation differentially affects quantitative mRNA measurements of endogenous reference genes in human placenta. , 2013, Placenta.

[64]  A. Feizi,et al.  Risk factors of placental abruption , 2013, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[65]  G. Elmer,et al.  Neuroplasticity, axonal guidance and micro‐RNA genes are associated with morphine self‐administration behavior , 2013, Addiction biology.

[66]  Marie J. Hayes,et al.  Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. , 2013, JAMA.

[67]  Marie J. Hayes,et al.  Neonatal Abstinence Syndrome: Treatment and Pediatric Outcomes , 2013, Clinical obstetrics and gynecology.

[68]  Martin J. Aryee,et al.  Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in Rheumatoid Arthritis , 2013, Nature Biotechnology.

[69]  R. Weksberg,et al.  Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray , 2013, Epigenetics.

[70]  A. Malek.  Effects of Prenatal Cocaine Exposure on Human Pregnancy and Postpartum , 2012 .

[71]  E. Albrecht,et al.  Phosphorylation of cyclic AMP‐response element–binding protein (CREB) is influenced by melatonin treatment in pancreatic rat insulinoma β‐cells (INS‐1) , 2012, Journal of pineal research.

[72]  A. Doehring,et al.  Genetic-epigenetic interaction modulates μ-opioid receptor regulation. , 2012, Human molecular genetics.

[73]  R. Chou,et al.  Medical and psychological risks and consequences of long-term opioid therapy in women. , 2012, Pain medicine.

[74]  R. Hardeland.  Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction , 2012, TheScientificWorldJournal.

[75]  D. Young,et al.  Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. , 2012, Osteoarthritis and cartilage.

[76]  B. Stacey,et al.  Sex differences in long-term opioid use: cautionary notes for prescribing in women. , 2012, Archives of internal medicine.

[77]  M. Hudak,et al.  Neonatal Drug Withdrawal , 2012, Pediatrics.

[78]  K. Lui,et al.  Dopamine D2 receptor gene polymorphisms in newborn infants of drug-using women , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[79]  C. Flores.  Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system. , 2011, Journal of psychiatry & neuroscience : JPN.

[80]  R. Quirion,et al.  Blockade of adrenomedullin receptors reverses morphine tolerance and its neurochemical mechanisms , 2011, Behavioural Brain Research.

[81]  M. Lynskey,et al.  Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts. , 2011, Journal of opioid management.

[82]  H. Jones,et al.  Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. , 2010, Addiction.

[83]  H. Ikeda,et al.  Morphine Modulation of Thrombospondin Levels in Astrocytes and Its Implications for Neurite Outgrowth and Synapse Formation* , 2010, The Journal of Biological Chemistry.

[84]  R. Quirion,et al.  A Role for Protein Kinase C-Dependent Upregulation of Adrenomedullin in the Development of Morphine Tolerance in Male Rats , 2010, The Journal of Neuroscience.

[85]  L. Becerra,et al.  Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. , 2010, Brain : a journal of neurology.

[86]  Gary A. Churchill,et al.  Importance of randomization in microarray experimental designs with Illumina platforms , 2009, Nucleic acids research.

[87]  L. Lagasse,et al.  Novel Biomarkers of Prenatal Methamphetamine Exposure in Human Meconium , 2009, Therapeutic drug monitoring.

[88]  Max Kuhn,et al.  Building Predictive Models in R Using the caret Package , 2008 .

[89]  L. Jansson,et al.  The Opioid Dependent Mother and Newborn Dyad: Nonpharmacologic Care , 2008, Journal of addiction medicine.

[90]  A. Lawrence,et al.  The Nuclear Transcription Factor CREB: Involvement in Addiction, Deletion Models and Looking Forward , 2007, Current neuropharmacology.

[91]  L. Wright,et al.  Low Birth Weight and Preterm Births: Etiologic Fraction Attributable to Prenatal Drug Exposure , 2005, Journal of Perinatology.

[92]  A. Smit,et al.  Morphine exposure and abstinence define specific stages of gene expression in the rat nucleus accumbens , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[93]  M C Neale,et al.  Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. , 2000, Archives of general psychiatry.

[94]  K. Mcculloch,et al.  Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis. , 1997, Journal of perinatology : official journal of the California Perinatal Association.

[95]  S. Kandall,et al.  Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. , 1993, The Journal of pediatrics.

[96]  A. Panerai,et al.  EEG sleep patterns and endogenous opioids in infants of narcotic-addicted mothers. , 1983, Revue d'electroencephalographie et de neurophysiologie clinique.

[97]  P. Mantegazza,et al.  Plasma β-Endorphin, β-Lipotropin, and Met-Enkephalin Concentrations during Pregnancy in Normal and Drug-Addicted Women and Their Newborn , 1983 .

[98]  Marie J. Hayes,et al.  Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity , 2017, The American journal on addictions.

[99]  G. Fan,et al.  DNA Methylation and Its Basic Function , 2013, Neuropsychopharmacology.